BIOplastics BV
Europe based BIOplastics BV is the innovative high quality injection moulding manufacturer of (q)PCR
consumables supplying the molecular (diagnostic) (q)PCR marketplace (MDX). BIOplastics with its sole
headquarter and manufacturing facility in Landgraaf, The Netherlands is a member of the privately owned
BIOzym Holding group, which is comprised of CYCLERtest BV, GENO-tronics BV, BIOzymTC BV, BPCTi Inc.
(USA), Hendrikx Ltd. (China) and CelsiusLabs. BIOplastics offers the most superior range of (q)PCR plastics
globally. BIOplastics pursues the vision to design and manufacture plastic consumables in particular for use in
MDX and related application fields as well as to supply MDX kit manufacturers. BIOplastics superior quality
and highly reproducible consumables allows ease of use with maximum reproducibility of results.
BIOplastics products are, in addition to being integrated into MDX kits, offered through a worldwide network
of selected distributors and resellers.
Michael T. Hendrikx. CEO BIOplastics BV
BIOplastics BV Strategic Views
The molecular (diagnostics) marketplace is rapidly growing and requires superior, independent and complete
supply of (q) PCR disposables. These demands require generation of accurate, consistent, and reproducible
results to manage and reduce variations in the (q)PCR process.
BIOzym Holding, the Netherlands, the parent company of BIOplastics and its sister company CYCLERtest,
support and commit to these demands and strategically organize all members to develop new products whose
end result is to comply with these "manage and reduce variations in the (q)PCR process” demands.
While CYCLERtest supplies independent ISO17025 accredited (q)PCR cycler tools and calibrations for all
models and brands of (q)PCR cyclers, BIOplastics manufactures Extreme Uniform q(PCR) disposables, and has
been able to reduce to the use of just two products for those who require the lowest variability, the number of
to be used products to a minimum of two.
BIOplastics is proud to be categorized as global innovative leader and we are obligated and eager to
maintain this position.